Health
Manulife launches new learning platform for its insurance advisors across Asia
* New digital platform elevates Manulife insurance advisors' careers and helps meet the region's growing health and retirement needs. * ManuAcademy accessible now to more than 60,000 advisors in Vietnam and soon to be available to tens of thousands more inHong Kong, Indonesia, Malaysia, and t...
2022-07-04 11:11
6383
Investing in people to reach their full potential - An impactful part of one CEO's journey towards creating a sustainable world
PETALING JAYA, Malaysia, July 4, 2022 /PRNewswire/ -- In a book aptly named " The Book of Wisdom" recently published by the Entrepreneurs Organization (EO) of Malaysia, Mr. Lim Boon Siong, CEO of VISTA Eye Specialist was asked for words of wisdom to share with readers, to which he replied "When you...
2022-07-04 08:30
2016
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
HANGZHOU and SHAOXING, China, July 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for functional cure of human immunodeficiency virus (HIV) infection, which was initiated by Shangh...
2022-07-04 08:10
2282
Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis
SAN FRANCISCO and SUZHOU, China, July 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and ot...
2022-07-04 08:00
2554
Brii Biosciences Exercises Option for Vir Biotechnology's VIR-3434, a Broadly Neutralizing Monoclonal Antibody Targeting Hepatitis B in Greater China
Exclusive development and commercialization rights to VIR-3434 in China strengthen Company's leadership and robust clinical pipeline in HBV Key partnership with Vir enables multitude of combination treatment options as part of Company's strategic approach to developing a functional cure for HBV ...
2022-07-04 07:10
2816
Chubb Life Announces Gail Costa Will Lead Newly Acquired Life Insurance Operations of Cigna in New Zealand
HONG KONG, July 4, 2022 /PRNewswire/ -- Chubb Life today announced that Gail Costa will lead the company's life insurance operations inNew Zealand that were recently acquired from Cigna. Ms. Costa, who is currently Chief Executive Officer of Cigna Life New Zealand, will continue to have executive...
2022-07-04 03:00
3350
IMG Partners with eMed to Provide Telehealth Proctored COVID-19 Tests to Groups of International Travelers
INDIANAPOLIS, July 1, 2022 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning global insurance benefits and assistance services company, has announced a new partnership with eMed, the architect behind the first virtually guided, rapid at-home COVID-19 certified test technology ...
2022-07-01 21:00
7971
Chubb Completes Acquisition of Cigna's Personal Accident, Supplemental Health and Life Insurance Business in Asia-Pacific
ZURICH, July 1, 2022 /PRNewswire/ -- Chubb Limited (NYSE: CB) today announced that it has completed its acquisition of the life and non-life insurance companies that house the personal accident, supplemental health and life insurance business of Cigna (NYSE: CI) in sixAsia-Pacific markets. Chubb ...
2022-07-01 15:02
4320
GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia
Building public trust and educating on the importance of getting vaccinated KUALA LUMPUR, Malaysia, July 1, 2022 /PRNewswire/ -- GSK is a science-led global healthcare company, delivering vaccines that help protect people at all stages of life. GSK's new purpose is to unite science, technology an...
2022-07-01 09:16
2883
Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS
GOTHENBURG, Sweden, July 1, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) ("Mentice") Mentice today confirms the acquisition of the Ankyras business from Galgo Medical SL, as previously communicated via the press release on9th June 2022, now has been completed. The information was submitted for re...
2022-07-01 03:42
2476
Tencent Cloud and Millennium Technology Services Roll Out i-Care to Connect Patients, Families and Caregivers, Delivering Seamless Comfort Care Anytime, Anywhere
The Tencent Cloud-backed solution aims to help improve patients' experience and quality of life SINGAPORE, June 30, 2022 /PRNewswire/ -- Customers' habits and expectations have evolved dramatically over the last few years across various industries including the medical and healthcare field, driv...
2022-06-30 22:00
4315
Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover
HONG KONG, June 30, 2022 /PRNewswire/ -- The Bund Finance Center (BFC) in Shanghai officially resumed dine-in services at restaurants starting from 29 June. At present, Fosun's businesses and shopping centers inShanghai, including the BFC, Yuyuan Tourist Mart, Forte Woli City, and Orstar City Zhe...
2022-06-30 20:43
3885
Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms
- Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire® - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment - 87.8% said they would recommend treatmen...
2022-06-30 19:00
2076
Australian developed VIRALEZE™ nasal spray relaunched by LloydsPharmacy in the UK
MELBOURNE, Australia, June 30, 2022 /PRNewswire/ -- UK consumers will again be able to buy VIRALEZE™, an easy-to-use barrier nasal spray, from LloydsPharmacy, following its relaunch online, with instore availability to follow shortly. Extensive antiviral testing undertaken at the globally renowne...
2022-06-30 12:41
1374
DigiconAsia readers honor Asia Pacific's digital innovators
The inaugural DigiconAsia DX Solution Excellence Awards
2022-06-30 12:00
2783
Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan
SHANGHAI, June 30, 2022 /PRNewswire/ -- Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has expanded its primary packaging capabi...
2022-06-30 08:00
2559
Israel Honors Pfizer CEO Albert Bourla with the "Jewish Nobel" Prize
Bourla donates his $1 million Genesis Prize award towards the construction of the Holocaust Museum ofGreece in Thessaloniki, to commemorate Greek-Jewish communities wiped out by the Nazis JERUSALEM, June 30, 2022 /PRNewswire/ -- Today the President of Israel Isaac Herzog presented the Genesis Pr...
2022-06-30 07:56
1931
Eurofins DiscoverX Celebrates Shanghai Office Opening
SHANGHAI, June 30, 2022 /PRNewswire/ -- Eurofins DiscoverX (Eurofins DiscoverX
Products LLC), a global industry leader of products for small and large
molecule drug discovery and QC lot release, today announced the official
opening of its newChina biotechnology office in Shanghai.
2022-06-30 01:00
2634
Insurance providers can assess customer health risks in real-time using contactless vital sign monitoring solution from NuraLogix
LAS VEGAS, June 29, 2022 /PRNewswire/ -- Insurance providers are now able to evaluate customer health risks in real-time using a revolutionary contactless wellness and vital sign monitoring solution fromNuraLogix. The application allows insurance providers to quickly perform a customer health ...
2022-06-29 21:05
2242
BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ Ventures
NEW YORK, June 29, 2022 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") is pleased to announce that its client,BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has successfully entered into a co-development agreement withGenFleet Therapeutics, Inc., an immuno-oncology focused biopharmaceutical company b...
2022-06-29 20:00
2378
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7889
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6989
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4283
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2919